Table 2 SCORing results of AD patients.
Patient | Gender | Age | Total cell dose | Injection Route | Follow-up (months) | Extent | Intensity | Pruritus/Insomnia | Total score | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | Â | Â | Â | Â | Pre | Post | Pre | Post | Pre | Post | Pre | Post |
1 | F | 27y | 6 × 108 | Intravenous | 5 1/2 | 98 | 98 | 17 | 11 | 14 | 3 | 93.1 | 61.1 |
2 | M | 33y | 6 × 108 | Intravenous | 4 1/2 | 75 | 75 | 7 | 5 | 14 | 3 | 57 | 35.5 |
3 | F | 27y | 1 × 109 | Intravenous | 3 1/2 | 12 | 7 | 8 | 4 | 3 | 1 | 33.4 | 16.4 |
4 | F | 26y | 6 × 108 | Intravenous | 2 | 18 | 4 | 7 | 3 | 11 | 2 | 39.1 | 13.3 |